Abstract
Investigations of neurodegeneration in humans and animals caused by prions have produced many unexpected and striking findings. For many years three uncommon human diseases and several animal disorders were labeled transmissible encephalopathies, spongiform encephalopathies, or slow virus diseases (GAJDUSEK 1977, 1985; SIGURDSSON 1954). These illnesses are transmissible to experimental animals after a prolonged incubation period, and some features of the transmissible pathogen resemble those of viruses. However, early attempts to characterize the infectious pathogen causing scrapie of sheep and goats argue that these transmissible agents differ from both viruses and viroids (ALPER et al. 1967; HUNTER 1972).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alper T, Cramp WA, Haig DA, Clarke MC (1967) Does the agent of scrapie replicate without nucleic acid? Nature 214:764–766
Baker HF, Poulter M, Crow TJ, Frith CD, Lofthouse R, Ridley RM (1991) Amino acid polymorphism in human prion protein and age at death in inherited prion disease. Lancet 337:1286
Bertoni JM, Brown P, Goldfarb L, Gajdusek D, Omaha NE (1992) Familial Creutzfeldt-Jakob disease with the PRNP codon 200lys mutation and supranuclear palsy but without myoclonus or periodic EEG complexes. Neurology 42 [4, Suppl 3]: 350 (abstract)
Bockman JM, Prusiner SB, Tateishi J, Kingsbury DT (1987) Immunoblotting of Creutzfeldt-Jakob disease prion proteins: host species-specific epitopes. Ann Neurol 21: 589 – 595
Borchelt DR, Scott M, Taraboulos A, Stahl N, Prusiner SB (1990) Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol 110: 743 – 752
Brown P, Rodgers-Johnson P, Cathala F, Gibbs CJ Jr, Gajdusek DC (1984) Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis. Ann Neurol 16: 295 – 304
Brown P, Cathala F, Castaigne P, Gajdusek DC (1986) Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol 20: 597 – 602
Brown P, Goldfarb LG, McCombie WR, Nieto A, Squillacote D, Sheremata W, Little BW, Godec MS, Gibbs CJ Jr, Gajdusek DC (1992) Atypical Creutzfeldt-Jakob disease in an American family with an insert mutation in the PRNP amyloid precursor gene. Neurology 42: 422 – 427
Brown P, Kaur P, Sulima MP, Goldfarb LG, Gibbs CJJ, Gajdusek DC (1993) Real and imagined clincopathological limits of “prion dementia.” Lancet 341: 127 – 129
Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp H-P, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C (1922) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356: 577 – 582
Büeler H, Aguzzi A, Sailer A, Greiner R-A, Autenried P, Aguet M, Weissmann C (1993) Mice devoid of PrP are resistant to scrapie. Cell 73: 1339 – 1347
Carlson GA, Kingsbury DT, Goodman PA, Coleman S, Marshall ST, DeArmond SJ, Westaway D, Prusiner SB (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46: 503 – 511
Collinge J, Palmer M (1991) CJD discrepancy. Nature 353: 802
Collinge J, Harding AE, Owen F, Poulter M, Lofthouse R, Boughey AM, Shah T, Crow TJ (1989) Diagnosis of Gerstmann-Sträussler syndrome in familial dementia with prion protein gene analysis. Lancet 2: 15 – 17
Collinge J, Owen F, Poulter H, Leach M, Crow T, Rosser M, Hardy J, Mullan H, Janota I, Lantos P (1990) Prion dementia without characteristic pathology. Lancet 336: 7 – 9
Collinge J, Brown J, Hardy J, Mullan M, Rossor MN, Baker H, Crow TJ, Lofthouse R, Poulter M, Ridley R, Owen F, Bennett C, Dunn G, Harding AE, Quinn N, Doshi B, Roberts GW, Honavar M, Janota I, Lantos PL (1992) Inherited prion disease with 144 base pair gene insertion. II. Clinical and pathological features. Brain 115: 687 – 710
Collinge J, Palmer MS, Campbell T, Sidle KCL, Carroll D, Harding A (1993) Inherited prion disease (PrP lysine 200) in Britain: two case reports. Br Med J 306: 391 – 392
Come JH, Fraser PE, Lansbury PT Jr (1993) A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 90: 5959 – 5963
Cousens SN, Harries-Jones R, Knight R, Will RG, Smith PG, Matthews WB (1990) Geographical distribution of cases of Creutzfeldt-Jakob disease in England and Wales 1970-84. J Neurol Neurosurg Psychiatry 53: 459 – 465
Crow TJ, Collinge J, Ridley RM, Baker HF, Lofthouse R, Owen F, Harding AE (1990) Mutations in the prion gene in human transmissible dementia. Seminar on molecular approaches to research in spongiform encephalopathies in man, Medical Research Council, London, 14 December 1990 (abstract)
Davison C, Rabiner AM (1940) Spastic pseudosclerosis (disseminated encephalomyelopathy; corticopal-lidospinal degeneration). Familial and nonfamilial incidence (a clinico-pathologic study). Arch Neurol Psychiatry 44: 578 – 598
Dlouhy SR, Hsiao K, Farlow MR, Foroud T, Conneally PM, Johnson P, Prusiner SB, Hodes ME, Ghetti B (1992) Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene. Nat Genet 1: 64 – 67
Doh-ura K, Tateishi J, Sasaki H, Kitamoto T, Sakaki Y (1989) Pro → Leu change at position 102 of prion protein is the most common but not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 163: 974 – 979
Doh-ura K, Kitamoto T, Sakaki Y, Tateishi J (1991) CJD discrepancy. Nature 353: 801 – 802
Forloni G, Angeretti N, Chiesa R, Monzani E, Salmona M, Bugiani O, Tagliavini F (1993) Neurotoxicity of a prion protein fragment. Nature 362: 543 – 546
Friede RL, DeJong RN (1964) Neuronal enzymatic failure in Creutzfeldt-Jakob disease. A familial study. Arch Neurol 10: 181 – 195
Gabizon R, Meiner Z, Cass C, Kahana E, Kahana I, Avrahami D, Abramsky O, Scarlato G, Prusiner SB, Hsiao KK (1991) Prion protein gene mutation in Libyan Jews with Creutzfeldt-Jakob disease. Neurology 41: 160
Gabizon R, Rosenmann H, Meiner Z, Kahana I, Kahana E, Shugart Y, Ott J, Prusiner SB (1993) Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease. Am J Hum Genet 33: 828 – 835
Gajdusek DC (1977) Unconventional viruses and the origin and disappearance of kuru. Science 197: 943 – 960
Gajdusek DC (1985) Subacute spongiform virus encephalopathies caused by unconventional viruses. In: Maramorosch K, McKelvey JJ Jr (eds) Subviral pathogens of plants and animals: viroids and prions. Academic, Orlando, pp 483 – 544
Gasset M, Baldwin MA, Lloyd D, Gabriel J-M, Holtzman DM, Cohen F, Fletterick R, Prusiner SB (1992) Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid. Proc Natl Acad Sci USA 89: 10940 – 10944
Gerstmann J, Straussler E, Scheinker I (1936) über eine eigenartige hereditär-familiäre Erkrankung des Zentralnervensystems Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Z Neurol 154: 736 – 762
Ghetti B, Tagliavini F, Masters CL, Beyreuther K, Giaccone G, Verga L, Farlo MR, Conneally PM, Dlouhy SR, Azzarelli B, Bugiani O (1989) Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in an affected family. Neurology 39: 1453 – 1461
Giaccone G, Tagliavini F, Verga L, Frangione B, Farlow MR, Bugiani O, Ghetti B (1990) Neurofibrillary tangles of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease share antigenic determinants with those of Alzheimer disease. Brain Res 530: 325 – 329
Goldfarb L, Brown P, Goldgaber D, Garruto R, Yanaghiara R, Asher D, Gajdusek DC (1990a) Identical mutation in unrelated patients with Creutzfeldt-Jakob disease. Lancet 336: 174 – 175
Goldfarb LG, Brown P, Goldgaber D, Asher DM, Rubenstein R, Brown WT, Piccardo P, Kascsak RJ, Boellaard JW, Gajdusek DC (1990b) Creutzfeldt-Jakob disease and kuru patients lack a mutation consistently found in the Gerstmann-Sträussler-Scheinker syndrome. Exp Neurol 108: 247 – 250
Goldfarb LG, Mitrova E, Brown P, Toh BH, Gajdusek DC (1990c) Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet 336: 514 – 515
Goldfarb LG, Brown P, McCombie WR, Goldgaber D, Swergold GD, Wills PR, Cervenakova L, Baron H, Gibbs CJJ, Gajdusek DC (1991a) Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 88: 10926 – 10930
Goldfarb LG, Brown P, Mitrova E, Cervenakova L, Goldin L, Korczyn AD, Chapman J, Galvez S, Cartier L, Rubenstein R, Gajdusek DC (1991b) Creutzfeldt-Jacob disease associated with the PRNP codon 200Lys mutation: an analysis of 45 families. Eur J Epidemiol 7: 477 – 486
Goldfarb LG, Haltia M, Brown P, Nieto A, Kovanen J, McCombie WR, Trapp S, Gajdusek DC (1991c) New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakob kindred. Lancet 337: 425
Goldfarb LG, Brown P, Haltia M, Cathala F, McCombie WR, Kovanen J, Cervenakova L, Goldin L, Nieto A, Godec MS, Asher DM, Gajdusek DC (1992a) Creutzfeldt-Jakob disease cosegregates with the codon 178Asn PRNP mutation in families of European origin. Ann Neurol 31: 274 – 281
Goldfarb LG, Petersen RB, Tabaton M, Brown P, LeBlanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P (1992b) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258: 806 – 808
Goldfarb LG, Brown P, Haltia M, Ghiso J, Frangione B, Gajdusek DC (1993) Synthetic peptides corresponding to different mutated regions of the amyloid gene in familial Creutzfeldt-Jakob disease show enhanced in vitro formation of morphologically different amyloid fibrils. Proc Natl Acad Sci USA 90: 4451 – 4454
Goldgaber D, Goldfarb LG, Brown P, Asher DM, Brown WT, Lin S, Teener JW, Feinstone SM, Rubenstein R, Kascsak RJ, Boellaard JW, Gajdusek DC (1989) Mutations in familial Creutzfeldt- Jakob disease and Gerstmann-Sträussler-Scheinker’s syndrome. Exp Neurol 106: 204 – 206
Goldhammer Y, Gabizon R, Meiner Z, Sadeh M (1993) An Israeli family with Gerstmann-Sträussler- Scheinker disease manifesting the codon 102 mutation in the prion protein gene. Neurology 43: 2718 – 2719
Harries-Jones R, Knight R, Will RG, Cousens S, Smith PG, Matthews WB (1988) Creutzfeldt-Jakob disease in England and Wales, 1980–1984: a case-contol study of potential risk factors. J Neurol Neurosurg Psychiatry 51: 1113 – 1119
Heston LL, Lowther DLW, Leventhal CM (1966) Alzheimer’s disease: a family study. Arch Neurol 15: 225 – 233
Hsiao K, Prusiner SB (1990) Inherited human prion diseases. Neurology 40: 1820 – 1827
Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Westaway D, Ott J, Prusiner SB (1989a) Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature 338: 342 – 345
Hsiao KK, Doh-ura K, Kitamoto T, Tateishi J, Prusiner SB (1989b) A prion protein amino acid substitution in ataxic Gerstmann-Sträussler syndrome. Ann Neurol 26: 137
Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB (1990) Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250: 1587 – 1590
Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abramsky O, Prusiner SB, Gabizon R (1991a) Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med 324: 1091 – 1097
Hsiao KK, Cass C, Schellenberg GD, Bird T, Devine-Gage E, Wisniewski H, Prusiner SB (1991b) A prion protein variant in a family with the telencephalic form of Gerstmann-Sträussler-Scheinker syndrome. Neurology 41: 681 – 684
Hsiao K, Dlouhy S, Farlow MR, Cass C, Da Costa M, Conneally M, Hodes ME, Ghetti B, Prusiner SB (1992) Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles. Nat Genet 1: 68 – 71
Hunter GD (1972) Scrapie: a prototype slow infection. J Infect Dis 125: 427 – 440
Ikeda S, Yanagisawa N, Allsop D, Glenner GG (1991) A variant of Gerstmann-Sträussler-Scheinker disease with β-protein epitopes and dystrophic neurites in the peripheral regions of PrP-immunoreactive amyloid plaques. In: Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, Westermark P (eds) Amyloid and amyloidosis 1990. Kluwer Academic, Dordrecht, pp 737 – 740
Jacob H, Pyrkosch W, Strube H (1950) Die erbliche Form der Creutzfeldt-Jakobschen Krankheit. Arch Psychiatr Z Neurol 184: 653 – 674
Kahana E, Milton A, Braham J, Sofer D (1974) Creutzfeldt-Jakob disease: focus among Libyan Jews in Israel. Science 183: 90 – 91
Kahana E, Zilber N, Abraham M (1991) Do Creutzfeldt-Jakob disease patients of Jewish Libyan origin have unique clinical features? Neurology 41: 1390 – 1392
Kirschbaum WR (1924) Zwei eigenartige Erkrankungen des Zentralnervensystems nach Art der spastischen Pseudosklerose (Jakob). Z Ges Neurol Psychiatr 92: 175 – 220
Kitamoto T (1993) Human prion diseases with PRNP polymorphisms. London 4
Kitamoto T, Tateishi J (1994) Human prion diseases with variant prion protein. Philos Trans R Soc Lond [Biol] 343: 391 – 398
Kitamoto T, lizuka R, Tateishi J (1993a) An amber mutation of prion protein in Gerstmann-Sträussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun 192: 25 – 531
Kitamoto T, Ohta M, Doh-ura K, Hitoshi S, Terao Y, Tateishi J (1993b) Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 191: 709 – 714
Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, DeArmond SJ (1986) Molecular cloning of a human prion protein cDNA. DNA 5: 315 – 324
Kretzschmar HA, Honold G, Seitelberger F, Feucht M, Wessely P, Mehraein P, Budka H (1991) Prion protein mutation in family first reported by Gerstmann, Straussler, and Scheinker. Lancet 337: 1160
Kretzschmar HA, Kufer P, Riethmüller G, DeArmond SJ, Prusiner SB, Schiffer D (1992) Prion protein mutation at codon 102 in an Italian family with Gerstmann-Sträussler-Scheinker syndrome. Neurology 42: 809 – 810
Lantos PL, McGill IS, Janota I, Doey LJ, Collinge J, Bruce MT, Whatley SA, Anderton BH, Clinton J, Roberts GW, Rossor MN (1992) Prion protein immunocytochemistry helps to establish the true incidence of prion diseases. Neurosci Lett 147: 67 – 71
Laplanche J-L, Chatelain J, Launay J-M, Gazengel C, Vidaud M (1990) Deletion in prion protein gene in a Moroccan family. Nucleic Acids Res 18: 6745
Little BVV, Brown PW, Rodgers-Johnson P, Perl DP, Gajdusek DC (1986) Familial myoclonic dementia masquerading as Creutzfeldt-Jakob disease. Ann Neurol 20: 231 – 239
Malmgren R, Kurland L, Mokri B, Kurtzke J (1979) The epidemiology of Creutzfeldt-Jakob disease. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 1. Academic, New York, pp 93 – 112
Manetto V, Medori R, Cortelli P, Montagna P, Tinuper P, Baruzzi A, Rancurel G, Hauw J-J, Vanderhaeghen J-J, Mailleux P, Bugiani 0, Tagliavini F, Bouras C, Rizszuto N, Lugaresi E, Gambetti P (1992) Fatal familial insomnia: clinical and pathological study of five new cases. Neurology 42: 312 – 319
Masters CL, Harris JO, Gajdusek DC, Gibbs CJ Jr, Bernouilli C, Asher DM (1978) Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familal and sporadic clustering. Ann Neurol 5: 177 – 188
Masters CL, Gajdusek DC, Gibbs CJ Jr, Bernouilli C, Asher DM (1979) Familial Creutzfeldt-Jakob disease and other familial dementias: an inquiry into possible models of virus-induced familial diseases. In: Prusiner SB, Hadlow WJ (eds) Slow transmissible diseases of the nervous system, vol 1. Academic, New York, pp 143 – 194
Medori R, Montagna P, Tritschler HJ, LeBlanc A, Cortelli P, Tinuper P, Lugaresi E, Gambetti P (1992) Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 42: 669 – 670
Meggendorfer F (1930) Klinische und genealogische Beobachtungen bei einem Fall von spastischer Pseudosklerose Jakobs. Z Ges Neurol Psychiatr 128: 337 – 341
Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB (1986) Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci USA 83: 2310 – 2314
Miyazono M, Kitamoto T, Doh-ura K, Iwaki T, Tateishi J (1992) Creutzfeldt-Jakob disease with codon 129 polymorphism (valine): a comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropathol (Berl) 84: 349 – 354
Nochlin D, Sumi SM, Bird TD, Snow AD, Leventhal CM, Beyreuther K, Masters CL (1989) Familial dementia with PrP-positive amyloid plaques: a variant of Gerstmann-Sträussler syndrome. Neurology 39: 910 – 918
Oesch B, Westaway D, Walchli M, McKinley MP, Kent SBH, Aebersold R, Barry RA, Tempst P, Teplow DB, Hood LE, Prusiner SB, Weissmann C (1985) A cellular gene encodes scrapie PrP 27–30 protein. Cell 40: 735 – 746
Owen F, Poulter M, Lofthouse R, Collinge J, CrowTJ, Risby D, Baker HF, Ridley RM, Hsiao K, Prusiner SB (1989) Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1: 51 – 52
Owen F, Poulter M, Collinge J, Crow TJ (1990a) Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet 46: 1215 – 1216
Owen F, Poulter M, Shah T, Collinge J, Lofthouse R, Baker H, Ridley R, McVey J, Crow T (1990b) An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jakob disease. Mol Brain Res 7: 273 – 276
Owen F, Poulter M, Collinge J, Leach M, Lofthouse R, Crow TJ, Harding AE (1992) A dementing illness associated with a novel insertion in the prion protein gene. Mol Brain Res 13: 155 – 157
Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352: 340 – 342
Palmer MS, Mahal SP, Campbell TA, Hill AF, Sidle KCL, Laplanche J-L, Collinge J (1993) Deletions in the prion protein gene are not associated with CJD. Hum Mol Genet 2: 541 – 544
Pan K-M, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, Prusiner SB (1993) Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci USA 90: 10962 – 10966
Pattison IH (1966) The relative susceptibility of sheep, goats and mice to two types of the goat scrapie agent. Res Vet Sci 7: 207 – 212
Pearlman RL, Towfighi J, Pezeshkpour GH, Tenser RB, Turel AP (1988) Clinical significance of types of cerebellar amyloid plaques in human spongiform encephalopathies. Neurology 38: 1249 – 1254
Petersen RB, Goldfarb L, Tabaton M, Brown P, LeBlanc A, Montagna P, Cortelli P, Monari L, Autilio-Gambetti L, Gajdusek DC, Lugaresi E, Gambetti P (1992) Fatal familial insomnia and one subtype of familial Creutzfeld-Jakob disease: effect of a polymorphism on a pathogenic mutation in the prion protein. FASEB J 7: A627
Pocchiari M, Salvatore M, Cutruzzola F, Genuardi M, Travaglini Allocated C, Masullo C, Macchi G, Alema G, Galgani S, Xi YG, Petraroli P, Silvestrini MC, Brunori M (1993) A new point mutation of the prion protein gene in familial and sporadic cases of Creutzfeldt-Jakob disease. Ann Neurol 34: 802 – 807
Poulter M, Baker HF, Frith CD, Leach M, Lofthouse R, Ridley RM, Shah T, Owen F, Collinge J, Brown G, Hardy J, Mullan MJ, Harding AE, Bennett C, Doshi R, Crow TJ (1992) Inherited prion disease with 144 base pair gene insertion. I. Genealogical and molecular studies. Brain 115: 675 – 685
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie Science 216: 136 – 144
Prusiner SB (1989) Scrapie prions. Annu Rev Microbiol 43: 345 – 374
Prusiner SB (1991) Molecular biology of prion diseases. Science 252: 1515 – 1522
Prusiner SB (1993) Genetic and infectious prion diseases. Arch Neurol 50: 1129 – 1153
Prusiner SB, McKinley MP, Groth DF, Bowman KA, Mock NI, Cochran SP, Masiarz FR (1981) Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci USA 78: 6675 – 6679
Prusiner SB, Groth DF, Bolton DC, Kent SB, Hood LE (1984) Purification and structural studies of a major scrapie prion protein. Cell 38: 127 – 134
Prusiner SB, Scott M, Foster D, Pan K-M, Groth D, Mirenda C, Torchia M, Yang S-L, Serban D, Carlson GA, Hoppe PC, Westaway D, DeArmond SJ (1990) Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63: 673 – 686
Prusiner SB, Fuzi M, Scott M, Serban D, Serban H, Taraboulos A, Gabriel J-M, Wells G, Wilesmith J, Bradley R, DeArmond SJ, Kristensson K (1993a) Immunologic and molecular biological studies of prion proteins in bovine spongiform encephalopathy. J Infect Dis 167: 602 – 613
Prusiner SB, Groth D, Serban A, Koehler R, Foster D, Torchia M, Burton D, Yang S-L, DeArmond SJ (1993b) Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc Natl Acad Sci USA 90: 10608 – 10612
Puckett C, Concannon P, Casey C, Hood L (1991) Genomic structure of the human prion protein gene. Am J Hum Genet 49: 320 – 329
Ripoll L, Laplanche J-L, Salzmann M, Jouvet A, Planques B, Dussaucy M, Chatelain J, Beaudry P, Launay J-M (1993) A new point mutation in the prion protein gene at codon 210 in Creutzfeldt-Jakob disease. Neurology 43: 1934 – 1938
Rosenthal NP, Keesey J, Crandall B, Brown WJ (1976) Familial neurological disease associated with spongiform encephalopathy. Arch Neurol 33: 252 – 259
Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M, Torchia M, Groth D, Carlson G, DeArmond SJ, Westaway D, Prusiner SB (1989) Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59: 847 – 857
Scott M, Groth D, Foster D, Torchia M, Yang S-L, DeArmond SJ, Prusiner SB (1993) Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73: 979 – 988
Sigurdsson B (1954) Rida, a chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics. Br Vet J 110: 341 – 354
Sparkes RS, Simon M, Cohn VH, Fournier REK, Lem J, Klisak I, Heinzmann C, Blatt C, Lucero M, Mohandas T, DeArmond SJ, Westaway D, Prusiner SB, Weiner LP (1986) Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci USA 83: 7358 – 7362
Stahl N, Baldwin MA, Teplow DB, Hood L, Gibson BW, Burlingame AL, Prusiner SB (1993) Structural analysis of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32: 1991 – 2002
Stender A (1930) Weitere Beiträge zum Kapitel “Spastische Pseudosklerose Jakobs.” Z Neurol Psychiatr 128: 528 – 543
Tagliavini F, Prelli F, Ghisto J, Bugiani O, Serban D, Prusiner SB, Farlow MR, Ghetti B, Frangione B (1991) Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11-kd fragment of prion protein with an N-terminal glycine at codon 58. EMBO J 10: 513 – 519
Tateishi J, Kitamoto T (1993) Developments in diagnosis for prion diseases. Br Med Bull 49: 971 – 979
Tateishi J, Kitamoto T, Doh-ura K, Sakaki Y, Steinmetz G, Tranchant C, Warter JM, Heldt N (1990) Immunochemical, molecular genetic, and transmission studies on a case of Gerstmann-Sträussler- Scheinker syndrome. Neurology 40: 1578 – 1581
Tateishi J, Doh-ura K, Kitamoto T, Tranchant C, Steinmetz G, Warter JM, Boellaard JW (1992) Prion protein gene analysis and transmission studies of Creutzfeldt-Jakob disease. In: Prusiner SB, Colinge J, Powell J, Anderton B (eds) Prion diseases of humans and animals. Horwood, London, pp 129 – 134
Udovitch AL, Valensi L (1984) The last Arab jews: the communities of Jerba, Tunisia. Harwood Academic, London
Vnencak-Jones CL, Phillips JA (1992) Identification of heterogeneous PrP gene deletions in controls by detection of allele-specific heteroduplexes (DASH). Am J Hum Genet 50:871–872
Westaway D, DeArmond SJ, Cayetano-Canlas J, Groth D, Foster D, Yang S-L, Torchia M, Carlson GA, Prusiner SB (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76:117–129
Wilesmith JW, Hoinville LJ, Ryan JBM, Sayers AR (1992) Bovine spongiform encephalopathy: aspects of the clinical picture and analyses of possible changes 1986–1990. Vet Rec 130:197–201
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Prusiner, S.B. (1996). Human Prion Diseases and Neurodegeneration. In: Prusiner, S.B. (eds) Prions Prions Prions. Current Topics in Microbiology and Immunology, vol 207. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60983-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-60983-1_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64640-9
Online ISBN: 978-3-642-60983-1
eBook Packages: Springer Book Archive